Applied Genetic Technologies Corporation (AGTC) Earns Daily News Impact Rating of 0.20

Media coverage about Applied Genetic Technologies Corporation (NASDAQ:AGTC) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Applied Genetic Technologies Corporation earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 47.3746189483893 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the media headlines that may have impacted Accern’s rankings:

Applied Genetic Technologies Corporation (NASDAQ AGTC) traded down $0.03 on Tuesday, hitting $3.75. The company had a trading volume of 82,700 shares, compared to its average volume of 171,277. Applied Genetic Technologies Corporation has a fifty-two week low of $3.25 and a fifty-two week high of $10.85.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) last posted its quarterly earnings data on Wednesday, September 13th. The biotechnology company reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.40). The company had revenue of $8.30 million for the quarter, compared to analyst estimates of $12.39 million. Applied Genetic Technologies Corporation had a negative net margin of 8.78% and a negative return on equity of 2.86%. The firm’s revenue was down 31.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.15 EPS. research analysts expect that Applied Genetic Technologies Corporation will post -0.81 EPS for the current year.

Several research firms have weighed in on AGTC. HC Wainwright set a $16.00 target price on Applied Genetic Technologies Corporation and gave the company a “buy” rating in a report on Thursday, August 10th. Stifel Nicolaus lowered their target price on Applied Genetic Technologies Corporation from $15.00 to $12.00 and set a “buy” rating on the stock in a report on Thursday, September 14th. ValuEngine lowered Applied Genetic Technologies Corporation from a “hold” rating to a “sell” rating in a report on Friday, September 15th. BMO Capital Markets reissued an “outperform” rating and issued a $7.00 target price (down previously from $14.00) on shares of Applied Genetic Technologies Corporation in a report on Thursday, September 14th. Finally, Wedbush reissued an “outperform” rating and issued a $9.00 target price on shares of Applied Genetic Technologies Corporation in a report on Wednesday, November 8th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. Applied Genetic Technologies Corporation has a consensus rating of “Hold” and an average price target of $10.17.

ILLEGAL ACTIVITY NOTICE: “Applied Genetic Technologies Corporation (AGTC) Earns Daily News Impact Rating of 0.20” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://sportsperspectives.com/2017/11/14/applied-genetic-technologies-corporation-agtc-earns-daily-news-impact-rating-of-0-20.html.

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP).

Insider Buying and Selling by Quarter for Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Receive News & Ratings for Applied Genetic Technologies Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Genetic Technologies Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply